SCHEMBL4564358

SCHEMBL4564358

OCCCCCC1=CC[CH]C=C1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BCHE P06276 3/20 0.33
ACHE P22303 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9516501 1.00 BCHE (0.33) BCHEACHE
SCHEMBL4434609 0.98 BCHE (0.30) BCHEACHE
SCHEMBL8149809 0.92
SCHEMBL22184230 0.71
SCHEMBL18997007 0.68 BCHE (0.32) BCHEACHE
SCHEMBL22098200 0.67 CYP4F2 (0.31)
SCHEMBL4316592 0.66
SCHEMBL4431152 0.65 BCHE (0.33) BCHEACHE
SCHEMBL5489483 0.63 CA2 (0.35) BCHEACHE
SCHEMBL6151243 0.63 CA2 (0.35) BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121609-A1 SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS Allergan, Inc. (US) 2009-11-25 EP claimed
WO-2008091818-A1 SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS ALLERGAN, INC. (US) 2008-07-31 WO claimed